Literature DB >> 31822494

Extracellular ATP and Purinergic P2Y2 Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage.

Isabel Schulien1,2, Birgit Hockenjos1, Veerle van Marck3, C Korcan Ayata4,5, Marie Follo6, Robert Thimme1, Peter Hasselblatt7.   

Abstract

Release of ATP to the extracellular compartment and subsequent activation of purinergic receptors is a conserved mechanism mediating inflammatory responses and cell fate decisions in various organs including the liver. Previous findings suggest that extracellular ATP may promote liver tumorigenesis, however, the underlying mechanisms are poorly understood. Therefore, our aim was to dissect the functions of extracellular ATP and P2Y2 receptors (P2Y2R) during hepatocarcinogenesis. Liver tumors were induced in wild-type and P2y2r -/- knockout mice by intraperitoneal diethylnitrosamine (DEN) injection. Tumorigenesis was analyzed after 8 to 10 months and molecular analyses were performed at different stages of tumorigenesis in vivo, as well as in primary mouse hepatocytes in vitro. Liver tumor incidence and tumor numbers were strongly reduced in P2y2r -/- mice, whereas tumor size and morphology were comparable to wild-type controls, suggesting that P2Y2R contributes to tumor initiation. Mechanistically, hepatocyte proliferation in DEN-treated P2y2r -/- mice was reduced, which correlated with reduced c-JUN and CCND1 but increased p21 expression. Moreover, DNA damage as determined by hepatocellular expression of γH2A.X and of genes related to genotoxic stress, as well as STAT3 phosphorylation, was reduced in the absence of P2y2r. Administration of genotoxic agents to primary hepatocytes in vitro confirmed that DNA damage was indeed exacerbated by extracellular ATP, subsequent P2Y2R activation, and downstream intracellular calcium-dependent signal transduction. In conclusion, our data reveal that extracellular ATP and subsequent P2Y2R function stimulate DNA damage responses and hepatocyte proliferation, thereby promoting hepatocarcinogenesis. Targeting this pathway may be an attractive approach for chemoprevention of hepatocellular carcinoma. SIGNIFICANCE: Extracellular ATP and subsequent P2Y2 receptor function stimulate DNA damage responses and hepatocyte proliferation, thereby promoting hepatocarcinogenesis in mice. Targeting this pathway may be an attractive approach for chemoprevention of hepatocellular carcinoma. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/4/699/F1.large.jpg. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31822494     DOI: 10.1158/0008-5472.CAN-19-1909

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  The P2 purinoceptors in prostate cancer.

Authors:  Zilin Wang; Sha Zhu; Sirui Tan; Yuhao Zeng; Hao Zeng
Journal:  Purinergic Signal       Date:  2022-06-30       Impact factor: 3.765

Review 2.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

3.  Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression.

Authors:  Caorui Lin; Ying Huang; Linjie Luo; Fengling Fang; Jiawei Zhang; Zhen Xun; Ya Fu; Hongyan Shang; Can Liu; Qishui Ou
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 4.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

Review 5.  P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Authors:  Lucas T Woods; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Gary A Weisman
Journal:  Biochem Pharmacol       Date:  2021-01-04       Impact factor: 5.858

6.  Activation of P2×7 Receptor Promotes the Invasion and Migration of Colon Cancer Cells via the STAT3 Signaling.

Authors:  Wen-Jun Zhang; Ce-Gui Hu; Hong-Liang Luo; Zheng-Ming Zhu
Journal:  Front Cell Dev Biol       Date:  2020-11-24

Review 7.  Structure-activity features of purines and their receptors: implications in cell physiopathology.

Authors:  Mauricio Díaz-Muñoz; Rolando Hernández-Muñoz; Armando Butanda-Ochoa
Journal:  Mol Biomed       Date:  2022-01-26

8.  Short- and intermediate-term exposure to ambient fine particulate elements and leukocyte epigenome-wide DNA methylation in older men: the Normative Aging Study.

Authors:  Cuicui Wang; Andres Cardenas; John N Hutchinson; Allan Just; Jonathan Heiss; Lifang Hou; Yinan Zheng; Brent A Coull; Anna Kosheleva; Petros Koutrakis; Andrea A Baccarelli; Joel D Schwartz
Journal:  Environ Int       Date:  2021-10-28       Impact factor: 9.621

9.  Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl4-Treated Fibrotic Mice.

Authors:  Erandi Velázquez-Miranda; Christian Molina-Aguilar; Adriana González-Gallardo; Olivia Vázquez-Martínez; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

Review 10.  Extracellular ATP: A Feasible Target for Cancer Therapy.

Authors:  Valentina Vultaggio-Poma; Alba Clara Sarti; Francesco Di Virgilio
Journal:  Cells       Date:  2020-11-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.